Status:
ACTIVE_NOT_RECRUITING
Personalized Breast Cancer Screening
Lead Sponsor:
Herlev and Gentofte Hospital
Collaborating Sponsors:
Danish Cancer Society
University of Cambridge
Conditions:
Breast Cancer
Eligibility:
FEMALE
50-67 years
Phase:
NA
Brief Summary
The purpose of the study is to measure short-term safety and efficacy of personalized vs. standard mammography screening among 50-67-year aged women. The CE-marked risk model incorporates genetic data...
Detailed Description
The screening program in Denmark has a very high quality, and overall Danish women\'s satisfaction with breast cancer screening is high. While breast cancer screening serves its purpose, its imple...
Eligibility Criteria
Inclusion
- Female sex
- Age between 50 and 67 (both included) years.
- Invited for the regular breast cancer mammography screening program
- Signed an informed consent
Exclusion
- Personal history of breast cancer
- Known high risk of breast cancer
- Ethnic origin, for which the risk model has not been validated.
Key Trial Info
Start Date :
February 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2034
Estimated Enrollment :
2200 Patients enrolled
Trial Details
Trial ID
NCT06060938
Start Date
February 2 2024
End Date
December 31 2034
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Breast Examinations, Herlev Gentofte Hospital, Copenhagen University Hospital
Gentofte Municipality, Denmark, 2900